Enovis Corporation (CFX)
NYSE · Healthcare
Enovis Corporation Revenue 2018–2021
Enovis Corporation annual/quarterly revenue history and growth rate from 2018 to 2022. Revenue can be defined as the amount of money a company receives from its customers in exchange for the sale of goods or services. Revenue is the top line item on an income statement from which all costs and expenses are subtracted to arrive at net income.
- Enovis Corporation revenue for the quarter ending March 31, 2022 was 1.0 B, a 16.40% increase year-over-year.
- Enovis Corporation revenue for the twelve months ending March 31, 2022 was 4.0 B.
- Enovis Corporation annual revenue for 2021 was 3.9 B, a 25.52% increase from 2020.
- Enovis Corporation annual revenue for 2020 was 3.1 B, a 7.71% decrease from 2019.
- Enovis Corporation annual revenue for 2019 was 3.3 B, a 9.25% decrease from 2018.
- Enovis Corporation annual revenue for 2018 was 3.7 B.
Revenue
TRAILING 12 MONTHS · $B
QUARTERLY · $B
YEAR-OVER-YEAR GROWTH · %
Enovis Corporation (CFX) — Frequently Asked Questions
Enovis Corporation (CFX) is a publicly traded US company. In fiscal 2021 it reported revenue of $3.85B and net income of $76M. Explore CFX's stock price, financial statements, earnings history, margins and key ratios below.
What is the CFX stock price?
CFX trades at $22.68 (-1.56% on the day).
How much revenue does Enovis Corporation make?
Enovis Corporation reported revenue of $3.85B in fiscal 2021.
Is CFX profitable?
In fiscal 2021, Enovis Corporation reported net income of $76M.